Literature DB >> 9085114

Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

P Cortina1, M J Gómez-Lechón, A Navea, J L Menezo, M C Terencio, M Diaz-Llopis.   

Abstract

PURPOSE: To investigate the effect of diclofenac sodium salt and cyclosporin A (CsA) on human lens epithelial cell (HLEC) growth in culture.
METHODS: Cultures of HLEC were obtained from anterior capsules from extracapsular cataract surgery. Third-passage cells were seeded in 96-well plates in 0.1 ml culture medium. Cytotoxicity was estimated by the tetrazolium test in confluent monolayers after 24 h exposure to a wide range of concentrations of diclofenac and CsA. The effect of subcytotoxic concentrations of diclofenac and CsA on HLEC proliferation in subconfluent cultures was evaluated after 24 and 72 h of exposure. To investigate the relationship between PGE2 synthesis and the inhibitory effect of these drugs, after 24 h of exposure to diclofenac and CsA the production of PGE2 was measured by radioimmunoassay. We also tested the effect of exogenous PGE2 addition to diclofenac 72-h-treated cultures.
RESULTS: Diclofenac and CsA (at concentrations > or = 65 microM and > or = 2.5 microM, respectively) inhibited the proliferation of subconfluent cultures of HLEC in a dose-dependent fashion. Diclofenac inhibits PGE2 synthesis, while CsA at high doses stimulates PGE2 synthesis of cultured HLEC. Exogenous PGE2 addition reversed in part the inhibitory effect of diclofenac.
CONCLUSIONS: Diclofenac and CsA at appropriate doses are effective in inhibiting cultured HLEC proliferation. This could be of interest to prevent posterior capsule opacification. Further in vivo experimental studies seem worthwhile.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9085114     DOI: 10.1007/bf00941726

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  39 in total

1.  Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests.

Authors:  E Borenfreund; H Babich; N Martin-Alguacil
Journal:  Toxicol In Vitro       Date:  1988       Impact factor: 3.500

Review 2.  Immunosuppressive drugs in immune and inflammatory ocular disease.

Authors:  R Hemady; J Tauber; C S Foster
Journal:  Surv Ophthalmol       Date:  1991 Mar-Apr       Impact factor: 6.048

3.  Pathogenesis of capsular opacification after extracapsular cataract extraction. An animal model.

Authors:  L M Cobo; E Ohsawa; D Chandler; R Arguello; G George
Journal:  Ophthalmology       Date:  1984-07       Impact factor: 12.079

4.  Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations.

Authors:  H H Radeke; S Kuster; V Kaever; K Resch
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Cyclosporin A: tissue levels following topical and systemic administration to rabbits.

Authors:  T A Bell; A G Hunnisett
Journal:  Br J Ophthalmol       Date:  1986-11       Impact factor: 4.638

6.  Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields.

Authors:  U Pleyer; B Elkins; D Rückert; S Lutz; J Grammer; J Chou; K H Schmidt; B J Mondino
Journal:  Curr Eye Res       Date:  1994-03       Impact factor: 2.424

7.  Alpha-tocopherol prevents cyclosporin A-mediated activation of phospholipase A2 and inhibition of Na+, K(+)-adenosine triphosphatase activity in cultured hamster renal tubular cells.

Authors:  R Anderson; C E Van Rensburg; M S Myer
Journal:  Toxicol Appl Pharmacol       Date:  1994-04       Impact factor: 4.219

8.  Secondary cataract. An in vivo model for studies on secondary cataract in rabbits.

Authors:  B Lundgren; E Jonsson; W Rolfsen
Journal:  Acta Ophthalmol Suppl       Date:  1992

9.  Ocular inflammatory effects of intravitreally injected interleukin-2.

Authors:  J R Samples; R S Boney; J T Rosenbaum
Journal:  Curr Eye Res       Date:  1993-07       Impact factor: 2.424

10.  Localisation of prostaglandin F2 alpha and E2 binding sites in the human eye.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

View more
  13 in total

Review 1.  [New methods for the prevention of posterior capsule opacification].

Authors:  G U Auffarth; T M Rabsilber; A J Reuland
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

2.  Outcome of phacoemulsification in patients with uveitis.

Authors:  M A Elgohary; P J McCluskey; H M A Towler; N Okhravi; R P Singh; R Obikpo; S S Lightman
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

3.  Cytoskeletal drugs prevent posterior capsular opacification in human lens capsule in vitro.

Authors:  Jeyalakshmi Sureshkumar; Aravind Haripriya; Veerappan Muthukkaruppan; Paul L Kaufman; Baohe Tian
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-12-03       Impact factor: 3.117

4.  A prospective evaluation of posterior capsule opacification in eyes with diabetes mellitus: a case-control study.

Authors:  M R Praveen; A R Vasavada; G D Shah; A R Shah; B M Khamar; K H Dave
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

5.  The effect of phosphorylated Akt inhibition on posterior capsule opacification in an ex vivo canine model.

Authors:  Heather L Chandler; Terah R Webb; Curtis A Barden; Mirunalni Thangavelu; Samuel K Kulp; Ching-Shih Chen; Carmen M H Colitz
Journal:  Mol Vis       Date:  2010-10-29       Impact factor: 2.367

6.  Application of sustained delivery microsphere of cyclosporine A for preventing posterior capsular opacification in rabbits.

Authors:  Cheng Pei; Yi Xu; Jean Xin Jiang; Li-Jun Cui; Li Li; Li Qin
Journal:  Int J Ophthalmol       Date:  2013-02-18       Impact factor: 1.779

7.  Prevention of posterior capsular opacification through aldose reductase inhibition.

Authors:  Umesh C S Yadav; Farshid Ighani-Hosseinabad; Frederik J G M van Kuijk; Satish K Srivastava; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

8.  Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.

Authors:  Heather L Chandler; Curtis A Barden; Ping Lu; Donna F Kusewitt; Carmen M H Colitz
Journal:  Mol Vis       Date:  2007-04-30       Impact factor: 2.367

Review 9.  Posterior Capsule Opacification: A Review of Experimental Studies.

Authors:  Joanna Konopińska; Maryla Młynarczyk; Diana Anna Dmuchowska; Iwona Obuchowska
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

10.  Post-operative capsular opacification: a review.

Authors:  Shetal M Raj; Abhay R Vasavada; S R Kaid Johar; Vaishali A Vasavada; Viraj A Vasavada
Journal:  Int J Biomed Sci       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.